Tables
Study | Year | Country | Setting | Sample Size | Follow-up Duration |
---|---|---|---|---|---|
1 | 2010 | USA | Hospital | 135 | 12 months |
2 | 2012 | UK | Hospital | 68 | NR |
3 | 2014 | France | Hospital | 45 | 6 months |
4 | 2016 | Spain | Hospital | 46 | NR |
5 | 2018 | Canada | Hospital | 27 | 3 years |
Total | 42 | Various | Various | 3,456 | NR |
Risk Factors | OR (95% CI) | P-value | I2 (%) |
---|---|---|---|
Age < 3 years | 2.34 (1.76–3.11) | <0.0001 | 46 |
Male sex | 1.45 (1.23–1.71) | 0.0001 | 0 |
Previous joint problems or surgery | 3.21 (2.15–4.79) | <0.0001 | 0 |
Immunodeficiency | 4.67 (3.12–6.99) | <0.0001 | 0 |
Recent infection or injury | 2.89 (2.03–4.11) | <0.0001 | 0 |
Clinical Features | OR/MD (95% CI) | P-value | I2 (%) | ||
---|---|---|---|---|---|
Fever | MD 38.7°C (38.5–38.9) | <0.00001 | 33 | ||
Joint pain | OR 9.87 (7.32–13.31) | <0.00001 | 65 | ||
Swelling | OR 8.54 (6.28–11.62) | <0.00001 | 53 | ||
Study | Year | Country | Setting | Sample Size | Follow-up Duration |
1 | 2010 | USA | Hospital | 135 | 12 months |
2 | 2012 | UK | Hospital | 68 | NR |
3 | 2014 | France | Hospital | 45 | 6 months |
4 | 2016 | Spain | Hospital | 46 | NR |
5 | 2018 | Canada | Hospital | 27 | 3 years |
... | ... | ... | ... | ... | ... |
Total | 42 | Various | Various | 3,456 | NR |
Clinical Features | OR/MD (95% CI) | P-value | I2 (%) |
---|---|---|---|
Fever | MD 38.7°C (38.5–38.9) | <0.00001 | 33 |
Joint pain | OR 9.87 (7.32–13.31) | <0.00001 | 65 |
Swelling | OR 8.54 (6.28–11.62) | <0.00001 | 53 |